Pharm'Up 
AbbVie has commenced construction on a $70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester, Massachusetts. This investment is part of AbbVie’s broader commitment to invest over $10 billion in the U.S. to bolster innovation and expand critical biologics manufacturing capacity.
Investment Details
- Location: AbbVie Bioresearch Center (ABC), Worcester, Massachusetts, U.S.
- Investment Amount: $70 million
- Goal: To expand domestic biologics manufacturing capacity to meet increased global demand and support U.S. production of current and next-generation oncology and immunology medicines.
- New Construction: The expansion includes additional biologics manufacturing areas and a new three-story building for laboratory, warehouse, and office space.
Strategic Impact
- Biologics Focus: The ABC site serves as a center of excellence for biologics research, development, and manufacturing. This expansion reinforces its role in developing and launching complex biologic medicines.
- Product Transfer: The new construction will facilitate the expedited transfer of select oncology products from Europe to the U.S.
- Job Creation: The project is expected to create new jobs at the ABC site, adding to AbbVie’s U.S. manufacturing footprint, which currently supports over 6,000 American jobs across 11 sites.
- Global Demand: The expanded capacity will help meet the growing global demand for AbbVie’s oncology and immunology products.
About the Author
